Bern University (2018). mTOR Inhibitor-Corticoid Combination Therapy For Multiple Sclerosis (WO 2018/153984 A1)
Full text not available from this repository. (Request a copy)The invention relates to a combination medicament for the treatment or therapy of multiple sclerosis, which comprises a corticosteroid and an inhibitor of mTOR. The corticosteroid and the inhibitor of mTOR may both be administered by intravenous injection or by enteral administration, or by a combination of oral and parenteral administration. The combination medicament is useful for the treatment of patients suffering from multiple sclerosis that does not respond to corticosteroid monotherapy.
Item Type: |
Patent |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Hoepner, Robert, Chan, Andrew Hao-Kuang |
Subjects: |
600 Technology > 610 Medicine & health |
Publisher: |
University of Bern |
Language: |
English |
Submitter: |
Panagiota Milona |
Date Deposited: |
28 Mar 2019 08:57 |
Last Modified: |
02 Mar 2023 23:31 |
Related URLs: |
|
URI: |
https://boris.unibe.ch/id/eprint/125517 |
Actions (login required)
 |
Edit item |